Clinical Trials Sponsored by Hangzhou Qihanjiyin Biotech Co.,Ltd.

Total 1065 results

Zhejiang University
Hangzhou Qihanjiyin Biotech Co.,Ltd.

Recruiting

Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

AML, Adult

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors (CSG-1827-101)

Advanced Solid Tumors

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG1906 for CLDN18.2-Positive Solid Tumors (CSG-1906-101)

Locally Advanced Unresectable or Metastatic Solid Tumors

China
Hangzhou Sumgen Biotech Co., Ltd.

Active, not recruiting

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

Relapsed or Refractory Multiple Myeloma | Hematological Malignancy

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG2918 For Advanced Malignant Tumors

Advanced Malignant Tumors

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.

Lymphoma | Hematological Malignancy

United States
Guangzhou Wondfo Biotech Co., Ltd

Suspended

Preview Rapid Strep A Test Method Comparison Study

Strep Throat

United States
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Herpes Zoster

Australia
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Withdrawn

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

SARS-CoV-2 | COVID-19 Vaccine

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Zhejiang University
Hangzhou Qihan Biotech Co.,Ltd.

Recruiting

Natural Killer(NK) Cell Therapy in r/r AML

AML, Adult

China
Zhejiang University
Hangzhou Qihangene Biotech Co.,Ltd.

Recruiting

Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

AML, Adult

China
Zhejiang University
Hangzhou Qihan Biotech Co.,Ltd.

Recruiting

Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia

AML, Adult

China
Zhejiang University
Hangzhou Qihan Biotech Co.,Ltd.

Recruiting

Natural Killer (NK) Cell Therapy for B-Cell Malignancies

B-cell Lymphoma | B-cell Acute Lymphoblastic Leukemia

China
Hangzhou Jiayin Biotech Ltd

Recruiting

A Study of EXG102-031 in Participants With wAMD

Neovascular Age-related Macular Degeneration

China
Hangzhou Jiayin Biotech Ltd

Recruiting

Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type 1

Spinal Muscular Atrophy Type I

China
Guangzhou Virotech Pharmaceutical Co., Ltd.

Recruiting

A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors

Solid Tumor

China
Guangzhou Virotech Pharmaceutical Co., Ltd.

Recruiting

A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors

Solid Tumor

Japan
Chengdu Kanghong Biotech Co., Ltd.
Guangzhou Keli Medical Research Co., Ltd.

Enrolling by invitation

Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data

Retinopathy of Prematurity

China
Xuanwu Hospital, Beijing
Guangzhou Recomgen Biotech Co., Ltd.

Recruiting

Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window (OPTION)

Acute Ischemic Stroke

China
Beijing Tiantan Hospital
Guangzhou Recomgen Biotech Co., Ltd.

Completed

Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ (TRACEⅡ)

Acute Ischemic Stroke

China
Hangzhou Converd Co., Ltd.

Recruiting

Safety of Recombinant Human IL-21 Oncolytic Vaccinia Virus Injection（hV01) in Advanced Tumors

Advanced Solid Tumors

China
HJB (Hangzhou) Co., Ltd.

Recruiting

TST002 Intervenous Injection in Postmenopausal Women and Men With Reduced Bone Mineral Density

Osteoporosis

China
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer (NOTABLE-308)

Refractory Metastatic Colorectal Cancer
Sinovac Biotech Co., Ltd

Not yet recruiting

Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indonesia

Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd

Recruiting

A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Seasonal Influenza

China
Hexaell Biotech Co., Ltd.

Recruiting

The Safety and Tolerability Study of HepaCure in Chinese Subjects With Acute-On-Chronic Liver Failure

Liver Failure | Hepatitis | Acute on Chronic Hepatic Failure

China
Oneness Biotech Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Mild to Moderate COVID-19

Taiwan, United States
SunWay Biotech Co., LTD.

Not yet recruiting

The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical Trial

Atopic Dermatitis | Atopic Dermatitis Eczema
Sinovac Biotech Co., Ltd

Not yet recruiting

An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)

Hand, Foot and Mouth Disease

China
Glac Biotech Co., Ltd

Recruiting

Probiotic on Atopic Dermatitis in Infant

Atopic Dermatitis

Taiwan
Sinovac Biotech Co., Ltd

Recruiting

A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Seasonal Influenza

China
Everfront Biotech Co., Ltd.

Not yet recruiting

A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer

Pancreatic Cancer
Meridigen Biotech Co., Ltd.

Not yet recruiting

Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)

Acute Respiratory Distress Syndrome

Taiwan
Sinovac Biotech Co., Ltd

Completed

Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants

Poliomyelitis

China
Oneness Biotech Co., Ltd.

Active, not recruiting

A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adults

Atopic Dermatitis

United States
Sinovac Biotech Co., Ltd

Completed

A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia

Hand, Foot and Mouth Disease

Indonesia
Sinovac Biotech Co., Ltd

Completed

Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infections

China
Sinovac Biotech Co., Ltd

Completed

Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infections

China
Oneness Biotech Co., Ltd.

Completed

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)

United States
Everfront Biotech Co., Ltd.

Active, not recruiting

A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma

Recurrent High Grade Glioma

Taiwan
Sinovac Biotech Co., Ltd

Completed

An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses

Poliomyelitis

China
Sinovac Biotech Co., Ltd

Completed

A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants

Poliomyelitis

China
Sinovac Biotech Co., Ltd

Completed

A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine

COVID-19

China
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infections

China
Sinovac Biotech Co., Ltd

Completed

Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Influenza and Pneumonia

China

3

Subscribe